Concord Wealth Partners Bio Techne Corp Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
A detailed history of Concord Wealth Partners transactions in Bio Techne Corp stock. As of the latest transaction made, Concord Wealth Partners holds 34 shares of TECH stock, worth $1,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 34
-0.0%
Holding current value
$1,615
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TECH
# of Institutions
616Shares Held
154MCall Options Held
161KPut Options Held
12.7K-
Vanguard Group Inc Valley Forge, PA18.6MShares$883 Million0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$712 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.7MShares$506 Million0.09% of portfolio
-
State Street Corp Boston, MA6.47MShares$308 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.76MShares$226 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $1.86B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...